Reporte zur Charge UT8817BA

Symptomtext

20 month old female was given fluzone hd with no reported adverse event; Initial information received on 09-Nov-2022 regarding an unsolicited valid non-serious case from other health professional. This case involves a 20-month-old female patient who was given influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 04-Nov-2022, the patient received suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at a dose of 0.5 ml once (lot UT8817BA, expiry date: 30-Jun-2023) via intramuscular route in the left thigh for immunization. On 04-Nov-2022, 20-month-old female was given fluzone hd with no reported adverse event (product administered to patient of inappropriate age, same day latency). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.